These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8180165)

  • 1. Mechanistic studies on human platelet isoprenylated protein methyltransferase: farnesylcysteine analogs block platelet aggregation without inhibiting the methyltransferase.
    Ma YT; Shi YQ; Lim YH; McGrail SH; Ware JA; Rando RR
    Biochemistry; 1994 May; 33(18):5414-20. PubMed ID: 8180165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyl-L-cysteine analogs can inhibit or initiate superoxide release by human neutrophils.
    Ding J; Lu DJ; Pérez-Sala D; Ma YT; Maddox JF; Gilbert BA; Badwey JA; Rando RR
    J Biol Chem; 1994 Jun; 269(24):16837-44. PubMed ID: 8207006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic mechanism of isoprenylated protein methyltransferase.
    Shi YQ; Rando RR
    J Biol Chem; 1992 May; 267(14):9547-51. PubMed ID: 1577795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel methyltransferase activity modifying the carboxy terminal bis(geranylgeranyl)-Cys-Ala-Cys structure of small GTP-binding proteins.
    Giner JL; Rando RR
    Biochemistry; 1994 Dec; 33(50):15116-23. PubMed ID: 7999771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms for auto-inhibition and forced product release in glycine N-methyltransferase: crystal structures of wild-type, mutant R175K and S-adenosylhomocysteine-bound R175K enzymes.
    Huang Y; Komoto J; Konishi K; Takata Y; Ogawa H; Gomi T; Fujioka M; Takusagawa F
    J Mol Biol; 2000 Apr; 298(1):149-62. PubMed ID: 10756111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Affinity labeling of histamine N-methyltransferase by 2',3'-dialdehyde derivatives of S-adenosylhomocysteine and S-adenosylmethionine. Kinetics of inactivation.
    Borchardt RT; Wu YS; Wu BS
    Biochemistry; 1978 Oct; 17(20):4145-52. PubMed ID: 708699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the kinetic mechanism of recombinant human isoprenylcysteine carboxylmethyltransferase (Icmt).
    Baron RA; Casey PJ
    BMC Biochem; 2004 Dec; 5():19. PubMed ID: 15625008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of prenylated protein methyltransferase in Leishmania.
    Hasne MP; Lawrence F
    Biochem J; 1999 Sep; 342 Pt 3(Pt 3):513-8. PubMed ID: 10477261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of the inhibition of transducin function by farnesylcysteine analogs.
    Parish CA; Brazil DP; Rando RR
    Biochemistry; 1997 Mar; 36(9):2686-93. PubMed ID: 9054576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Farnesylcysteine analogs to probe role of prenylated protein methyltransferase.
    Ma YT; Gilbert BA; Rando RR
    Methods Enzymol; 1995; 250():226-34. PubMed ID: 7651154
    [No Abstract]   [Full Text] [Related]  

  • 11. Amide-substituted farnesylcysteine analogs as inhibitors of human isoprenylcysteine carboxyl methyltransferase.
    Donelson JL; Hodges HB; Macdougall DD; Henriksen BS; Hrycyna CA; Gibbs RA
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4420-3. PubMed ID: 16777414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesylcysteine analogues inhibit store-regulated Ca2+ entry in human platelets: evidence for involvement of small GTP-binding proteins and actin cytoskeleton.
    Rosado JA; Sage SO
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):183-92. PubMed ID: 10727417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogs of farnesylcysteine induce apoptosis in HL-60 cells.
    Pérez-Sala D; Gilbert BA; Rando RR; Cañada FJ
    FEBS Lett; 1998 Apr; 426(3):319-24. PubMed ID: 9600259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying the recognition unit for G protein methylation.
    Tan EW; Pérez-Sala D; Cañada FJ; Rando RR
    J Biol Chem; 1991 Jun; 266(17):10719-22. PubMed ID: 1904056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of capacitative Ca2+ entry into cells by farnesylcysteine analogs.
    Xu Y; Gilbert BA; Rando RR; Chen L; Tashjian AH
    Mol Pharmacol; 1996 Dec; 50(6):1495-501. PubMed ID: 8967970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The uniquely distributed isoprenylated protein methyltransferase activity in the rat brain is highly expressed in the cerebellum.
    Ben Baruch G; Paz A; Marciano D; Egozi Y; Haklai R; Kloog Y
    Biochem Biophys Res Commun; 1993 Aug; 195(1):282-8. PubMed ID: 8363609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential arginine residues in isoprenylcysteine protein carboxyl methyltransferase.
    Boivin D; Lin W; Béliveau R
    Biochem Cell Biol; 1997; 75(1):63-9. PubMed ID: 9192075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesyl-L-cysteine analogs block SAM-induced Parkinson's disease-like symptoms in rats.
    Lamango NS; Charlton CG
    Pharmacol Biochem Behav; 2000 Aug; 66(4):841-9. PubMed ID: 10973524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single activity carboxyl methylates both farnesyl and geranylgeranyl cysteine residues.
    Volker C; Lane P; Kwee C; Johnson M; Stock J
    FEBS Lett; 1991 Dec; 295(1-3):189-94. PubMed ID: 1765152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma brucei prenylated-protein carboxyl methyltransferase prefers farnesylated substrates.
    Buckner FS; Kateete DP; Lubega GW; Van Voorhis WC; Yokoyama K
    Biochem J; 2002 Nov; 367(Pt 3):809-16. PubMed ID: 12141948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.